Interrupt processing system and method for information processing system
of pipeline control type
    1.
    发明授权
    Interrupt processing system and method for information processing system of pipeline control type 失效
    管道控制型信息处理系统中断处理系统及方法

    公开(公告)号:US6125443A

    公开(公告)日:2000-09-26

    申请号:US154715

    申请日:1998-09-17

    申请人: Chiaki Takahashi

    发明人: Chiaki Takahashi

    IPC分类号: G06F9/38 G06F9/48 G06F9/00

    CPC分类号: G06F9/3861 G06F9/3885

    摘要: An interrupt processing system and method for an information processing system of pipeline control type are disclosed. The occurrence of an exception is detected for each plurality of instructions to be processed in parallel. The occurrences of exceptions, when detected for a plurality of the instructions to be processed in parallel, are reported collectively according to each cause of the exceptions. In the case where the occurrences of exceptions are reported for a plurality of the instructions to be processed in parallel by an exception reporting unit, an interrupt request is issued. In response to the interrupt request, the pipeline processing is restored by an instruction control unit to the state before execution of the leading one of the plurality of the instructions to be processed in parallel for which the occurrences of exceptions are detected, and the instructions are reexecuted one by one sequentially from the leading one of the plurality of instructions through the instruction control unit. Thus, an interrupt is accurately processed upon occurrence of an exception.

    摘要翻译: 公开了一种用于管道控制类型的信息处理系统的中断处理系统和方法。 检测到要并行处理的每个多个指令的异常的发生。 当检测到并行处理的多个指令时,异常的发生是根据异常的每一个原因集体报告的。 在针对要由异常报告单元并行处理的多个指令报告异常发生的情况下,发出中断请求。 响应于中断请求,流水线处理由指令控制单元恢复到并行处理的多个待处理指令中的前导指令之前的状态,其中检测到异常发生,并且指令是 通过指令控制单元从多个指令的前导序列依次重新执行。 因此,在发生异常时,中断被精确地处理。

    Receptor protein and method for diagnosing inflammatory diseases by using the same
    2.
    发明授权
    Receptor protein and method for diagnosing inflammatory diseases by using the same 失效
    受体蛋白及其使用方法诊断炎性疾病

    公开(公告)号:US06777204B1

    公开(公告)日:2004-08-17

    申请号:US09786442

    申请日:2001-03-05

    IPC分类号: C12P2106

    摘要: Disclosed are a novel seven-pass transmembrane receptor protein found in immature dendritic cells and a DNA encoding the same. Further, disclosed are a replicable recombinant DNA which comprises a replicable expression vector and, operably inserted therein, the above-mentioned DNA; a cell of a microorganism or cell culture (transformant), which is transformed with the above-mentioned replicable recombinant DNA; a seven-pass transmembrane receptor protein which is produced on the cell surface of the above-mentioned transformant; a method for screening a ligand which binds to the above-mentioned seven-pass transmembrane receptor protein, and a method for screening a substance which inhibits the ligand from binding to the seven-pass transmembrane receptor protein; and an antibody which binds to the above-mentioned seven-pass transmembrane receptor protein. The present invention also discloses a method for the diagnosis of an inflammatory disease, such as rheumatism, which comprises determining the amount of the seven-pass transmembrane receptor protein expressed in human leukocytes.

    摘要翻译: 公开了一种在未成熟树突状细胞中发现的新型七遍跨膜受体蛋白和编码它的DNA。 此外,公开了可复制的重组DNA,其包含可复制的表达载体,并在其中可操作地插入上述DNA; 用上述可复制重组DNA转化的微生物或细胞培养物(转化体)的细胞; 在上述转化体的细胞表面产生的7次跨膜受体蛋白; 用于筛选结合上述七次跨膜受体蛋白质的配体的方法,以及筛选抑制配体与七次跨膜受体蛋白结合的物质的方法; 和结合上述七次跨膜受体蛋白的抗体。 本发明还公开了一种用于诊断炎性疾病如风湿病的方法,其包括测定人白细胞中表达的七次跨膜受体蛋白的量。